Skip to main content

Analysts Offer Insights on Real Estate Companies: Simon Property (SPG) and Healthpeak Properties (DOC)

Tipranks - Wed Feb 4, 7:46AM CST

Analysts fell to the sidelines weighing in on Simon Property (SPGResearch Report) and Healthpeak Properties (DOCResearch Report) with neutral ratings, indicating that the experts are neither bullish nor bearish on the stocks.

Claim 50% Off TipRanks Premium

Simon Property (SPG)

Scotiabank analyst Greg McGinniss maintained a Hold rating on Simon Property today and set a price target of $189.00. The company’s shares closed last Monday at $191.22.

According to TipRanks.com, McGinniss is a 1-star analyst with an average return of -1.6% and a 41.9% success rate. McGinniss covers the NA sector, focusing on stocks such as Rexford Industrial Realty, Gaming and Leisure, and Americold Realty. ;'>

Simon Property has an analyst consensus of Moderate Buy, with a price target consensus of $197.27, a 2.8% upside from current levels. In a report released yesterday, BMO Capital also maintained a Hold rating on the stock with a $200.00 price target.

See today’s best-performing stocks on TipRanks >>

Healthpeak Properties (DOC)

Scotiabank analyst Nicholas Yulico maintained a Hold rating on Healthpeak Properties today and set a price target of $19.00. The company’s shares closed last Monday at $16.92.

According to TipRanks.com, Yulico is a 3-star analyst with an average return of 1.7% and a 46.6% success rate. Yulico covers the NA sector, focusing on stocks such as SmartStop Self Storage REIT, Inc., American Healthcare REIT, Inc., and Essential Properties Realty. ;'>

The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Healthpeak Properties with a $19.00 average price target, representing a 10.6% upside. In a report released today, Wells Fargo also maintained a Hold rating on the stock with a $18.00 price target.

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.